Prognostic Value of the Neutrophil-to-Lymphocyte and Lymphocyte-to-Monocyte Ratios and Their Association with the International Prognostic Index in Patients with Diffuse Large B-Cell Lymphoma
Eurasian Journal of Medical Advances · 2026 · 6 (1) · 42-50
DOI: 10.14744/ejma.267042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medical Advances, 2026. Verfasst von Meltem Demirtaş Gülmez und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Objectives
We assessed the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) at diagnosis, their correlations with the International Prognostic Index (IPI), and their impact on survival in patients with diffuse large B-cell lymphoma (DLBCL) treated with rituximab-based regimens.
Methods
We retrospectively analyzed 139 patients with DLBCL at a single center between 2008 and 2019. Optimal cutoffs were determined by ROC analysis, survival was assessed using the Kaplan–Meier method, and independent predictors were identified using Cox regression analysis.
Results
The optimal cutoffs were 2.90 for NLR and 2.40 for LMR. Both NLR≥2.90 and LMR
Zitieren
APA
Gülmez, M. D., & Bilgir, O. (2026). Prognostic Value of the Neutrophil-to-Lymphocyte and Lymphocyte-to-Monocyte Ratios and Their Association with the International Prognostic Index in Patients with Diffuse Large B-Cell Lymphoma. Eurasian Journal of Medical Advances, 6(1), 42-50. https://doi.org/10.14744/ejma.267042
Vancouver
Gülmez MD, Bilgir O. Prognostic Value of the Neutrophil-to-Lymphocyte and Lymphocyte-to-Monocyte Ratios and Their Association with the International Prognostic Index in Patients with Diffuse Large B-Cell Lymphoma. Eurasian Journal of Medical Advances. 2026;6(1):42-50. doi:10.14744/ejma.267042
BibTeX
@article{Gulmez2026,
author = {Gülmez, Meltem Demirtaş and Bilgir, Oktay},
title = {Prognostic Value of the Neutrophil-to-Lymphocyte and Lymphocyte-to-Monocyte Ratios and Their Association with the International Prognostic Index in Patients with Diffuse Large B-Cell Lymphoma},
journal = {Eurasian Journal of Medical Advances},
year = {2026},
volume = {6},
number = {1},
pages = {42--50},
doi = {10.14744/ejma.267042}
}
EUVIMED